论文部分内容阅读
目的:观察中药补心气口服液治疗慢性稳定型心绞痛的疗效及其对患者生活质量的影响。方法:将63例经冠状动脉造影确诊为稳定型心绞痛的患者随机分为2组:补心气口服液组,给服补心气口服液10 ml,tid;硝酸酯类组,给服硝酸异山梨酯10 mg,tid或单硝酸异山梨酯20 mg,bid;治疗12周后,比较2组疗效,并采用西雅图心绞痛调查问卷(SAQ)生活质量测定量表,评价2组治疗后生活质量改善的情况。结果:2组心电图疗效比较,差异无统计学意义(P>0.05),在改善临床症状和生活质量方面,补心气口服液组明显优于硝酸酯类组(P<0.05)。结论:补心气口服液能有效改善心肌缺血和临床症状,并能提高患者的生活质量。
Objective: To observe the curative effect of Buxuqi oral liquid on chronic stable angina pectoris and its effect on quality of life of patients. Methods: Sixty-three patients with stable angina pectoris diagnosed by coronary angiography were randomly divided into two groups: Bu Xinqi oral liquid group, 10ml of tbuqi xinqi oral solution, tid; nitrate group, given isosorbide dinitrate 10 mg, tid or isosorbide mononitrate 20 mg bid; after 12 weeks of treatment, the two groups were compared and the quality of life of the two groups was evaluated by the SAQQQA . Results: There was no significant difference between the two groups in the curative effect of electrocardiogram (P> 0.05). BuXinGi Oral Liquid Group was superior to nitrates in improving clinical symptoms and quality of life (P <0.05). Conclusion: Bu Xin Qi oral liquid can effectively improve myocardial ischemia and clinical symptoms, and can improve the quality of life of patients.